Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes

Alejandro Soto-Gutiérrez, Naoya Kobayashi, Jorge David Rivas-Carrillo, Nalu Navarro-Alvarez, Debiao Zhao, Teru Okitsu, Hirofumi Noguchi, Hesham Basma, Yashuhiko Tabata, Yong Chen, Kimiaki Tanaka, Michiki Narushima, Atsushi Miki, Tadayoshi Ueda, Hee-Sook Jun, Ji-Won Yoon, Jane Lebkowski, Noriaki Tanaka, Ira J Fox

Research output: Contribution to journalArticlepeer-review


Severe acute liver failure, even when transient, must be treated by transplantation and lifelong immune suppression. Treatment could be improved by bioartificial liver (BAL) support, but this approach is hindered by a shortage of human hepatocytes. To generate an alternative source of cells for BAL support, we differentiated mouse embryonic stem (ES) cells into hepatocytes by coculture with a combination of human liver nonparenchymal cell lines and fibroblast growth factor-2, human activin-A and hepatocyte growth factor. Functional hepatocytes were isolated using albumin promoter-based cell sorting. ES cell-derived hepatocytes expressed liver-specific genes, secreted albumin and metabolized ammonia, lidocaine and diazepam. Treatment of 90% hepatectomized mice with a subcutaneously implanted BAL seeded with ES cell-derived hepatocytes or primary hepatocytes improved liver function and prolonged survival, whereas treatment with a BAL seeded with control cells did not. After functioning in the BAL, ES cell-derived hepatocytes developed characteristics nearly identical to those of primary hepatocytes.

Original languageEnglish
Pages (from-to)1412-9
Number of pages8
JournalNature Biotechnology
Issue number11
Publication statusPublished - Nov 2006


  • Activins
  • Animals
  • Cell Culture Techniques
  • Cell Differentiation
  • Cell Transplantation
  • Embryonic Stem Cells
  • Fibroblast Growth Factor 2
  • Hepatocyte Growth Factor
  • Hepatocytes
  • Humans
  • Liver Failure, Acute
  • Liver, Artificial
  • Mice
  • Models, Animal


Dive into the research topics of 'Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes'. Together they form a unique fingerprint.

Cite this